Inventor
EZAKI MASAMI
JP19 patents
⚠️ This page may combine multiple inventors who share the name “EZAKI MASAMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
18 patentsUS5037809AAug 6, 1991
Antimicrobial agent, FR109615 and production thereof
FUJISAWA PHARMACEUTICAL CO15 citations80
US6207434B1Mar 27, 2001
Process for the deacylation of cyclic lipopeptides
FUJISAWA PHARMACEUTICAL CO6 citations73
US5514715AMay 7, 1996
Antimicrobial agent, FR109615 and production thereof
FUJISAWA PHARMACEUTICAL CO8 citations71
US5279826AJan 18, 1994
Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
FUJISAWA PHARMACEUTICAL CO6 citations69
US6825003B2Nov 30, 2004
Cyclic lipopeptide acylase
FUJISAWA PHARMACEUTICAL CO1 citations62
US6573084B1Jun 3, 2003
Process for the deacylation of cyclic lipopeptides
FUJISAWA PHARMACEUTICAL CO1 citations62
US6537789B1Mar 25, 2003
Process for the deacylation of cyclic lipopeptides
FUJISAWA PHARMACEUTICAL CO1 citations62
US6372474B1Apr 16, 2002
Cyclic lipopeptide acylase
FUJISAWA PHARMACEUTICAL CO2 citations62
US5364624ANov 15, 1994
WS7622A mono- or di-sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5292510AMar 8, 1994
WS7622A mono- or di- sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5167958ADec 1, 1992
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use for treatment of pulmonary emphysema and adult respiratory distress syndrome
FUJISAWA PHARMACEUTICAL CO3 citations62
US5021240AJun 4, 1991
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations62
US4654211AMar 31, 1987
New compound, FR-900451, production and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5436140AJul 25, 1995
Process for producing WS-9326A and WS-9326B
FUJISAWA PHARMACEUTICAL CO4 citations61
US6521600B1Feb 18, 2003
Compound, WF002, production thereof and use thereof
FUJISAWA PHARMACEUTICAL CO0 citations51
US5217952AJun 8, 1993
Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
FUJISAWA PHARMACEUTICAL CO2 citations51
US4939241AJul 3, 1990
Amino acid derivatives of antitumor activity
FUJISAWA PHARMACEUTICAL CO1 citations51
US4950605AAug 21, 1990
FR-900493 substance, a process for its production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO1 citations50